Eosinophil cationic protein in nasal secretions and blood serum in grass-pollen allergic rhinitis

American Journal of Rhinology

Volumn 10, Issue 5, 1996, Pages 319-322

  Klimek, L ^a   Riechelmann, H ^a   Amedee, R ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000905668     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065896782159738     Document Type: Article

References (25)

1. Adelroth E, Rosenhall L, Johansson SA, et al. Inflammatory cells and eosinophil activity in asthmatics investigated by bronchoalveolar lavage. Am Rev Resp Dis 142:91-99, 1990.
2. Andersson M, Andersson P, Venge P, Pipkorn U. Eosinophils and eosinophil cationic protein in nasal lavages in allergeninduced hyperresponsiveness: Effects of topical glucocorticosteroid treatment. Allergy 44:342-348, 1989.
3. Bascom R, Pipkorn U, Gleich G, et al. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic corticosteroids. Am Rev Resp Dis 138:40612, 1988.
4. Bisgaard H, Gronborg H, Mygind N, et al. Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: Effect of the glucocorticoid budesonide. J Allergy Clin Immunol 85:891-895, 1990.
5. Bonini S, Tomassini M, Adrian! E, et al. Markers of eosinophilic inflammation in allergic diseases. Allergy 48:133-137, 1993.
6. Cohen AB, Goldberg S, London RL. Immunoglobulins in nasal secretions of infants. Clin Exp Immunol 6:753-757, 1970.
7. Dahl R. Eosinophil and eosinophil products. In: N Mygind, U Pipkorn (Eds.) Allergic and vasomotor rhinitis: Pathophysiological aspects. Munksgaard, Copenhagen, Denmark, pp 136139, 1987.
8. Fujieda S, Noda I, Sugimoto C, et al. Effect of pretreatment with Ketotifen on pollinosis: Correlation with eosinophil cationic protein. Am J Rhinol 8:49-53, 1994.
9. Kersten W, Puls KE. Pollenflug-Vorhersage. Allergologie 7:81- 114, 1984.
10. Klementsson H. Time relation between allergen-induced changes in nasal responsiveness and eosinophil granulocytes. Rhinology 32:90-91, 1994.
11. Linder A, Ronquist G, Deuschl H. Random distribution of exogenous lithium in nasal secretion and its application in substance determination. Acta Otolaryngol 96:287-293, 1983.
12. Linder A, Venge P, Deuschl H. Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis. Allergy 42:583-590, 1987.
13. Mann W. Ultraschalldiagnostik. Arch Oto-Rhino-Laryngol. (Suppl. I) 71-98, 1989.
14. Messerklinger W. Technik und Möglichkeiten der Nasenendoskopie. HNO 20:133-135, 1972.
15. Naclerio RM, Proud D, Peters SP, et al. Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy 16:101110, 1986.
16. Nishioka K, Saito C, Nagano T, et al. Eosinophil cationic protein in the nasal secretions of patients with mite allergic rhinitis. Laryngoscope 103:189-192, 1993.
17. Pedersen B, Dahl R, Larsen BB, Venge P. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X. Allergy 48:377-382, 1993.
18. Pharmacia: ECP-RIA-Directions for use. Kabi Pharmacia Diagnostics AB, Uppsala, Sweden, Rev. Ed. 1992.
19. Pipkom U, Karlsen G, Enerbäck L. Cellular response of the human allergic nasal mucosa to natural allergen exposure. J Allergy Clin Immunol 82:1046-1054, 1989.
20. Rak S, Björnson A, Hakansson L, et al. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 88:878-888, 1991.
21. Schmekel B, Venge P. Markers for eosinophils and T-lymphocytes as predictors of late asthmatic response. Allergy 48:94-97, 1993.
22. Svensson C, Andersson M, Persson CGA, et al. Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol 5:828-833, 1990.
23. Toorerenbergen van AW, Wijk van RG, Vermeulen AM, Zijlstra FJ. Increase of albumin, eosinophil cationic protein, histamine, leukotriens, and mast cell tryptase in nasal lavage fluid after challenge with inhalant allergen extract. Agents Actions 8:421424, 1992.
24. Venge P, Roxin LE, Olsson I. Radioimmunoassay of human eosinophil cationic protein. Br J Haematol 37:331-335, 1977.
25. Venge P. Soluble markers of allergic inflammation. Allergy 49:1-8, 1994. D